[02:26] I'm so excited to have this conversation, and I think you're going to find it really helpful
Full disclaimer Obesity medicine providers in Charleston prescribe semaglutide, tirzepatide
The blog covers functional nutrition, chronic conditions, gut health, hormonal health, autoimmune conditions, sleep, mental health, and root cause analysis
Abcam, Cambridge, UK) and mouse monoclonal anti-glucagon antibody (1:100 dilution, Sigma)
Important safety considerations include an increased risk of hypoglycaemia when used with insulin or sulfonylureas (dose reductions of these medications may be needed), potential risk of pancreatitis (seek urgent medical attention for severe, persistent abdominal pain), gallbladder disease, and risk of dehydration or acute kidney injury with severe gastrointestinal events
and by reducing adverse events often the #1 reason that patients stop using GLP-1 drugs Lexarias proprietary DehydraTECH technology could be of vital importance to any of these companies in their pursuit of the next oral GLP-1 drugs, the company explains
